Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:659-666

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pislaru, S. V.
Right arrow Articles by Van de Werf, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pislaru, S. V.
Right arrow Articles by Van de Werf, F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cardiomyopathy
*Heart Attack

(Circulation. 1997;96:659-666.)
© 1997 American Heart Association, Inc.


Articles

Infarct Size, Myocardial Hemorrhage, and Recovery of Function After Mechanical Versus Pharmacological Reperfusion

Effects of Lytic State and Occlusion Time

Sorin V. Pislaru, MD; Laurentino Barrios, MD, PhD; Tony Stassen; Lin Jun, MD; Cristina Pislaru, MD; ; Frans Van de Werf, MD, PhD

From the Department of Cardiology, Gasthuisberg University Hospital, Leuven, Belgium.

Correspondence to Frans Van de Werf, MD, PhD, Department of Cardiology, U.Z. Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. E-mail frans.vandewerf{at}uz.kuleuven.ac.be

Background Whether myocardial reperfusion obtained with thrombolysis or primary angioplasty is associated with a similar recovery of function and with the same risk of hemorrhagic infarction is unknown. We evaluated the effects of mechanical and pharmacological reperfusion (with or without a plasma lytic state) on infarct size, myocardial hemorrhage, and left ventricular (LV) function in a canine model.

Methods and Results Six groups of six dogs were subjected to balloon occlusion of the left anterior descending coronary artery (LAD) followed by 2 hours of reperfusion. The study had a two-by-three factorial design with two occlusion periods (90 and 240 minutes) and three different reperfusion strategies (placebo, 0.4 mg/kg recombinant tissue plasminogen activator, and 40 µg/kg recombinant staphylokinase). In a seventh control group, LAD occlusion was maintained without reperfusion. All dogs received aspirin and heparin. A systemic lytic state was present in staphylokinase-treated dogs. Planimetry of LV slices showed larger infarcts (percent of area at risk) and more hemorrhage (percent of IA) after 240 minutes of occlusion than after 90 minutes of occlusion (54±17% versus 37±18% and 52±27% versus 29±27%, respectively; P<.01 for both comparisons), with no significant difference among treatments. Hemorrhage was not observed in the control group without reperfusion. LV angiography showed no differences in global and regional LV function between mechanical and pharmacological reperfusion.

Conclusions In this experimental model, hemorrhagic infarctions of similar extent were observed after both pharmacological and mechanical reperfusion. The extent of hemorrhage was increased by the delay in reperfusion but not by the presence of a lytic state.


Key Words: thrombolysis • angioplasty • myocardial infarction • reperfusion




This article has been cited by other articles:


Home page
Eur Heart JHome page
J. Ganame, G. Messalli, S. Dymarkowski, F. E. Rademakers, W. Desmet, F. Van de Werf, and J. Bogaert
Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction
Eur. Heart J., June 2, 2009; 30(12): 1440 - 1449.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. P. O'Regan, R. Ahmed, N. Karunanithy, C. Neuwirth, Y. Tan, G. Durighel, J. V. Hajnal, I. Nadra, S. J. Corbett, and S. A. Cook
Reperfusion Hemorrhage Following Acute Myocardial Infarction: Assessment with T2* Mapping and Effect on Measuring the Area at Risk
Radiology, March 1, 2009; 250(3): 916 - 922.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Zhu, Y. Qiu, Q. Wang, Y. Zhu, S. Hu, L. Zheng, L. Wang, and Y. Zhang
Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats
Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 661 - 666.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Kawamoto, H. Iwasaki, K. Kusano, T. Murayama, A. Oyamada, M. Silver, C. Hulbert, M. Gavin, A. Hanley, H. Ma, et al.
CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells
Circulation, November 14, 2006; 114(20): 2163 - 2169.
[Abstract] [Full Text] [PDF]